Neuropathic Pain and Type II Diabetic Patients
Launched by BILECIK SEYH EDEBALI UNIVERSITESI · Jan 28, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of diabetic peripheral neuropathy (DPN) in adults with type II diabetes. DPN is a common problem for people with diabetes that can cause symptoms like numbness, tingling, muscle weakness, and painful sensations that can feel like burning or electric shocks. These symptoms often get worse at night and can make it hard to sleep, walk, or carry out daily activities, ultimately affecting a person's quality of life.
To participate in this trial, you need to be at least 18 years old and have been diagnosed with type II diabetes. You should be able to read and write in Turkish and have no serious communication barriers. The trial is currently recruiting participants, and it welcomes individuals of all genders. If you join, you can expect to be part of a study that aims to better understand how DPN affects daily life and how to improve the quality of life for those living with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older,
- • Diagnosed with type II diabetes,
- • Reading and writing,
- • No physical or psychological communication barriers,
- • Can read and speak Turkish,
- • Volunteers
- Exclusion Criteria:
- • Diagnosed with type I diabetes
About Bilecik Seyh Edebali Universitesi
Bilecik Seyh Edebali University is a reputable academic institution located in Turkey, dedicated to advancing research and education in various fields, including medical and clinical sciences. With a strong emphasis on innovation and community health, the university actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. Collaborating with local and international partners, Bilecik Seyh Edebali University is committed to rigorous research methodologies, ethical standards, and the dissemination of knowledge, fostering an environment that supports the development of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bilecik, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported